Pentasa (mesalazine)

About Zeria Pharmaceutical

Zeria Pharmaceutical's mission is to contribute to human health through the development and provision of high-quality pharmaceutical and healthcare products. The company has achieved a robust market position in Japan, particularly in gastroenterology, and has built a sustainable business model through a diversified portfolio spanning prescription drugs, OTC products, and nutraceuticals. Its strategy focuses on lifecycle management of core assets, strategic in-licensing, and targeted expansion into high-growth Asian consumer health markets. Zeria's financial strength, evidenced by its significant market cap, supports steady R&D investment and strategic partnerships.

Therapeutic Areas